Treatment of Cocaine Dependence With Lisdexamfetamine

Summary

This protocol is a 2-group double-blind placebo-controlled outpatient study investigating lisdexamfetamine for treatment of cocaine dependence. The investigators plan to enroll 100 subjects in a 14-week trial. The primary objectives will determine changes in cocaine use and secondary objectives will be cocaine craving and impulsivity.

Timeline

Start

2009-07

Primary completion

2013-01

Completion

2013-01

Drugs

Indications